{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:53:04Z","timestamp":1754146384224,"version":"3.41.2"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl. Int."],"abstract":"<jats:p>A standardized approach to assessing islet autotransplantation outcomes is crucial for evaluating graft function and guiding clinical decisions. This study compares the performance of existing classification systems\u2014Milan, Minneapolis, Chicago, Leicester, Igls, and a novel Data-Driven approach\u2014by evaluating their ability to differentiate transplant outcomes using metabolic and insulin secretion parameters. Our analysis shows strong concordance among Milan, Minneapolis, Chicago, and Igls, primarily due to minor variations in C-peptide thresholds. The Leicester and Data-Driven systems, however, exhibit greater divergence, with the Leicester system simplifying assessment by excluding severe hypoglycemic events and HbA1c, and the Data-Driven approach offering a more dynamic framework without predefined thresholds. Fasting C-peptide levels emerged as a highly reliable predictor of graft function, with the arginine test proving more effective than Mixed Meal Tolerance Test for additional evaluation. The Data-Driven approach provided superior stratification of outcomes, highlighting the importance of residual insulin secretion in metabolic control. These findings suggest that refining classification systems, particularly by considering insulin sensitivity and residual secretion, could enhance long-term patient monitoring and improve our understanding of beta-cell replacement therapies. Further validation across diverse cohorts is essential for broader clinical adoption.<\/jats:p>","DOI":"10.3389\/ti.2025.14714","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T05:10:19Z","timestamp":1752815419000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Analysis of Islet Auto-Transplantation Outcome Classification Systems: Evaluating Concordance, Feasibility, and a Data-Driven Approach"],"prefix":"10.3389","volume":"38","author":[{"given":"Davide","family":"Catarinella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Magistretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Melzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Mercalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tentori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Gremizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Paloschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libera","family":"Valla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Aleotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"De Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Caldara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Piemonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00125-018-4588-0","article-title":"Defining Outcomes for Beta Cell Replacement Therapy: A Work in Progress","volume":"61","author":"Piemonti","year":"2018","journal-title":"Diabetologia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1097\/TP.0000000000002158","article-title":"Defining Outcomes for \u0392-Cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria from the Ipita\/Epita Opinion Leaders Workshop","volume":"102","author":"Rickels","year":"2018","journal-title":"Transplantation"},{"key":"B3","first-page":"343","article-title":"Defining Outcomes for \u03b2-Cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria from the IPITA\/EPITA Opinion Leaders Workshop","volume-title":"Transpl Int","author":"Rickels","year":"2018"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1210\/clinem\/dgab386","article-title":"Examination of the Igls Criteria for Defining Functional Outcomes of \u0392-Cell Replacement Therapy: Ipita Symposium Report","volume":"106","author":"Landstra","year":"2021","journal-title":"The J Clin Endocrinol & Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1097\/tp.0000000000005050","article-title":"Success with Islet Autotransplantation for Pancreatic Neoplasia Using a Careful Approach","volume":"108","author":"Bellin","year":"2024","journal-title":"Transplantation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/SLA.0000000000005713","article-title":"Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-Risk Pancreatojejunostomy After Pancreaticoduodenectomy: A Prospective Randomized Trial","volume":"277","author":"Balzano","year":"2023","journal-title":"Ann Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/ajt.13656","article-title":"Autologous Islet Transplantation in Patients Requiring Pancreatectomy: A Broader Spectrum of Indications Beyond Chronic Pancreatitis","volume":"16","author":"Balzano","year":"2016","journal-title":"Am J Transpl"},{"key":"B8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11892-014-0512-2","article-title":"Autologous Islet Transplantation in Patients Requiring Pancreatectomy for Neoplasm","volume":"14","author":"Balzano","year":"2014","journal-title":"Curr Diab Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/17446651.2023.2256407","article-title":"Current Practices in Islet Cell Autotransplantation","volume":"18","author":"Chen","year":"2023","journal-title":"Expert Rev Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/xcs.0000000000001294","article-title":"Long-Term Islet Graft Functional Assessment in More than 500 Patients Undergoing Total Pancreatectomy with Intraportal Islet Autotransplantation","volume":"240","author":"Bellin","year":"2025","journal-title":"J Am Coll Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1097\/TP.0000000000005037","article-title":"Autologous Pancreatic Islet Cell Transplantation Following Pancreatectomy for Pancreas Diseases Other than Chronic Pancreatitis: A 15-Y Study of the Milan Protocol","volume":"108","author":"Piemonti","year":"2024","journal-title":"Transplantation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/tri.13762","article-title":"Performance of Modified Igls Criteria to Evaluate Islet Autograft Function After Total Pancreatectomy with Islet Autotransplantation\u2013a Retrospective Study","volume":"34","author":"McEachron","year":"2021","journal-title":"Transpl Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/tri.13364","article-title":"Assessment of Simple Indices Based on a Single Fasting Blood Sample as a Tool to Estimate beta-cell Function After Total Pancreatectomy with Islet Autotransplantation - A Prospective Study","volume":"32","author":"Go\u0142\u0119biewska","year":"2019","journal-title":"Transpl Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.21037\/hbsn-21-558","article-title":"Assessment of Long-Term Graft Function Following Total Pancreatectomy and Autologous Islet Transplantation: The Leicester Experience","volume":"12","author":"Pollard","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and Abuse of Homa Modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/TP.0b013e31822ca79b","article-title":"Comparative Evaluation of Simple Indices of Graft Function After Islet Transplantation","volume":"92","author":"Caumo","year":"2011","journal-title":"Transplantation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2337\/diab.43.9.1157","article-title":"Hyperinsulinemia Decreases Second-phase but Not First-phase Arginine-Induced Insulin Release in Humans","volume":"43","author":"Piatti","year":"1994","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e15106","DOI":"10.1111\/ctr.15106","article-title":"Islet Graft Function by Mixed Meal Tolerance Testing Is Sustained Over 4 Years in Young Children Undergoing Total Pancreatectomy With Islet Autotransplantation","volume":"37","author":"Gnikpingo","year":"2023","journal-title":"Clin Transpl"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e14814","DOI":"10.1111\/dme.14814","article-title":"Capturing the Real-World Benefit of Residual \u0392-Cell Function During Clinically Important Time-Periods in Established Type 1 Diabetes","volume":"39","author":"Taylor","year":"2022","journal-title":"Diabet Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2337\/db13-0881","article-title":"Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial","volume":"63","author":"Lachin","year":"2014","journal-title":"Diabetes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2337\/dc14-1952","article-title":"Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes","volume":"38","author":"Davis","year":"2015","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/dme.12850","article-title":"Low Levels of C-Peptide Have Clinical Significance for Established Type 1 Diabetes","volume":"32","author":"Kuhtreiber","year":"2015","journal-title":"Diabet Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/14737159.2016.1210513","article-title":"The Clinical Potential of Low-Level C-Peptide Secretion","volume":"16","author":"Ludvigsson","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"B24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s00125-020-05099-3","article-title":"Preserved C-Peptide Secretion Is Associated with Fewer Low-Glucose Events and Lower Glucose Variability on Flash Glucose Monitoring in Adults with Type 1 Diabetes","volume":"63","author":"Gibb","year":"2020","journal-title":"Diabetologia"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2025.14714\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T05:10:21Z","timestamp":1752815421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2025.14714\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":24,"alternative-id":["10.3389\/ti.2025.14714"],"URL":"https:\/\/doi.org\/10.3389\/ti.2025.14714","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"article-number":"14714"}}